Local insight.Global impact.
CCHO helps government health agencies, payers and drug developers across the Middle East and North Africa make better-informed healthcare decisions, with health economics, real-world evidence and market access expertise built in the region.
Our Policy, HEOR and PROM teams present 12 posters on real-world evidence, EQ-5D-5L valuation and health economics from the Middle East and North Africa.
From evidence to patient access across the Middle East and North Africa.
The first university diploma in health economics and outcomes research designed for the Middle East and North Africa: 6 courses and a capstone project over 10 months, for working professionals anywhere in the world.
The UAE’s first EQ-5D-5L value set, built on how the UAE population itself rates health, with UAE University, the American University of Beirut and the Dubai and Abu Dhabi health authorities. Published in Value in Health.
Congress posters developed with ministries of health in the region, and open webinars on health economics and patient-reported outcomes.
CCHO is a multidisciplinary team of health economists, epidemiologists, clinicians, policy analysts and academics. We generate the evidence that healthcare decisions in the MENA region rely on, advise on the access strategies and health policies that bring new treatments and technologies to patients, and train the professionals who make those decisions.
Who we areOur researchers are multilingual (Arabic, English and French) and bring more than 20 years of combined experience in the pharmaceutical industry and public health.
Meet the teamAccess to medicine across the MENA region is our guiding mission. Four principles shape how we work.
Insight into MENA health systems, payer requirements and patient needs.
Robust methods, and a clear understanding of who decides.
A broad stakeholder network across the Middle East and North Africa.
A research partnership approach that builds lasting relationships.
Read more about our educational collaborationsBefore a new treatment reaches patients in the MENA region, someone has to show it works in local practice, that it’s worth its cost, and how health systems can pay for it. CCHO helps you build that case, with regionally recognized, multilingual researchers who know how decisions are made in each market.
Every project is designed around your objectives.
Studies based on data from everyday clinical practice in the region, to support value and access decisions.
Learn moreMeasuring what matters to patients: PROMs and PREMs selection, development, validation and Arabic adaptation.
Learn moreCost-effectiveness, budget impact and burden-of-disease studies built for MENA health systems.
Learn morePricing and reimbursement strategy, launch readiness and managed entry agreements.
Learn moreResearch with payers and clinicians, advisory boards and engagement strategy.
Learn moreHEOR, HTA and market access workshops in English, French and Arabic.
Learn moreValue dossiers, regulatory submissions and scientific publications.
Learn moreHealth economics and outcomes research underpins everything we do. See how our solutions combine for your program.
All solutionsCollaboration is one of our four pillars. Beyond our day-to-day projects, we invest in the people and the evidence that healthcare decisions in the region depend on: training the next generation of HEOR professionals with the region’s universities, and building local reference data such as EQ-5D value sets.
The first university diploma in health economics and outcomes research designed for the Middle East and North Africa.
The UAE’s first EQ-5D-5L value set, based on interviews with 1,005 adults across all seven emirates. Published in Value in Health, 2025.
About the studyDeveloping a value set for EQ-5D-5L health states based on the preferences of Qatar’s general adult population, with Hamad Medical Corporation, Qatar University and the EuroQol Research Foundation. Interim results will be presented at ISPOR Europe 2026 in Vienna.
12 posters on real-world evidence, EQ-5D-5L valuation and health economics from the Middle East and North Africa.
See our poster scheduleHow PROs bring the patient’s perspective into treatment decisions, the measurement properties of PRO measures, and their place in Saudi Vision 2030.
Read moreWe’re looking for people who care about health economics and outcomes research and want their work to reach patients. Join a team in Beirut, Dubai and Riyadh that lives by four pillars: Clarity, Credibility, Connection and Collaboration.
Apply to join usTell us about your evidence or access challenge in the MENA region. We reply within two business days.
